Does the Conversol (liver‑support supplement) interfere with levothyroxine therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Conversol (Liver-Support Supplement) Interfere with Levothyroxine?

Without knowing the specific ingredients in Conversol, it is impossible to definitively state whether it interferes with levothyroxine absorption, but liver-support supplements commonly contain ingredients that are known to interfere with levothyroxine—you should separate Conversol from levothyroxine by at least 4 hours and monitor TSH levels 4-8 weeks after starting the supplement.

Understanding the Problem

The critical issue is that many supplements and medications interfere with levothyroxine absorption through several mechanisms:

  • Direct chelation/complexing in the gastrointestinal tract
  • Alteration of gastric pH affecting dissolution
  • Binding to levothyroxine preventing absorption

Common Liver-Support Supplement Ingredients That Interfere

Liver-support supplements typically contain ingredients that are documented to interfere with levothyroxine:

Calcium and Iron

If Conversol contains calcium or iron (common in liver supplements), these directly bind to levothyroxine and significantly reduce absorption 1. Studies demonstrate that calcium carbonate and ferrous sulfate form insoluble complexes with levothyroxine in the intestinal lumen 2, 3.

Fiber and Herbal Components

Many liver supplements contain fiber or herbal ingredients that can interfere with levothyroxine absorption 4, 3.

Antioxidants and Minerals

Supplements containing chromium have been shown to significantly decrease levothyroxine absorption 5.

Clinical Recommendations

Timing Strategy

Administer levothyroxine at least 4 hours before or after Conversol 6, 1. The FDA label explicitly states: "Administer levothyroxine sodium tablets at least 4 hours before or after drugs known to interfere with levothyroxine sodium absorption" 1.

Monitoring Protocol

  • Check TSH 4-8 weeks after starting Conversol 6
  • Continue monitoring every 4-8 weeks until stable euthyroid indices are documented 6
  • If TSH becomes elevated, increase levothyroxine dose accordingly

Optimal Levothyroxine Administration

Take levothyroxine 30-60 minutes before breakfast with water on an empty stomach 6. This maximizes absorption and minimizes interaction potential with any supplements taken later in the day.

Alternative Approach

If separation timing proves difficult for compliance, consider liquid levothyroxine formulations, which have been shown to circumvent absorption issues caused by multiple interfering substances including calcium, iron, and pH-altering agents 7, 8. These formulations can sometimes be taken simultaneously with interfering substances.

Critical Caveat

The specific ingredients in Conversol matter immensely. Request the complete ingredient list from the patient or manufacturer. If it contains calcium, iron, fiber, chromium, or pH-altering substances, interference is highly likely. Even without these specific ingredients, the prudent approach is to separate administration times given the unpredictable nature of supplement formulations 2, 4.

Bottom Line Algorithm

  1. Separate dosing by 4+ hours (levothyroxine first, Conversol later)
  2. Check TSH in 4-8 weeks
  3. If TSH elevated: increase levothyroxine dose by 12.5-25 mcg increments 6
  4. If compliance issues: consider liquid levothyroxine formulation 7, 8
  5. Recheck TSH 4-8 weeks after any dose adjustment until stable 6

The guideline is clear: levothyroxine "should not be taken with substances or medications that interfere with its absorption" 6, and the safest approach with any supplement of uncertain composition is temporal separation and vigilant monitoring.

References

Research

Conditions and drugs interfering with thyroxine absorption.

Best practice & research. Clinical endocrinology & metabolism, 2009

Research

New medications which decrease levothyroxine absorption.

Thyroid : official journal of the American Thyroid Association, 2007

Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.